| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |